The Association of Antibiotic (ATB) exposure prior to immune checkpoint inhibitor (ICI) treatment on early emergency room and hospitalization utilization: A population-based study.

Authors

Lawson Eng

Lawson Eng

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

Lawson Eng, Rinku Sutradhar, Yue Niu, Ning Liu, Ying Liu, Yosuf Kaliwal, Melanie Lynn Powis, Geoffrey Liu, Jeffrey M. Peppercorn, Philippe L. Bedard, Monika K. Krzyzanowska

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Patient Experience; Quality, Safety, and Implementation Science; Technology and Innovation in Quality of Care

Track

Technology and Innovation in Quality of Care,Patient Experience,Quality, Safety, and Implementation Science,Cost, Value, and Policy,Health Care Access, Equity, and Disparities

Sub Track

Real-World Evidence

Citation

J Clin Oncol 39, 2021 (suppl 28; abstr 304)

DOI

10.1200/JCO.2020.39.28_suppl.304

Abstract #

304

Poster Bd #

Online Only

Abstract Disclosures

Funded by Conquer Cancer

Similar Posters

First Author: Lawson Eng

First Author: Fauzia Riaz

Poster

2022 ASCO Annual Meeting

Immune-related adverse effects of long-term PD-1/PD-L1 inhibtor treatment.

Immune-related adverse effects of long-term PD-1/PD-L1 inhibtor treatment.

First Author: Sarah Kim